Evidence map›Paper›PMID 41984531›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Fibronectin1-Expressing Subicular Circuits Selectively Govern the Retrieval of Novel Object Recognition.

Fan Fei, Jiaying Shi, Jing Xi, Yixiang Xu, Shuye Ying, Xukun Fan, Wangjialu Lu, Zhisheng Li, Menghan Li, Yu Wang and 6 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Fan FeiZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Jiaying ShiInstitute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Jing XiInstitute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Yixiang XuZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Shuye YingZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Xukun FanZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Wangjialu LuInstitute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Zhisheng LiInstitute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Menghan LiZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Yu WangZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Li ChengZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Lin YangZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Lingyu XuZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Zhong ChenZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Cenglin XuZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Yi WangZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.ORCID https://orcid.org/0000-0002-1350-2961

Funding

National Key Research and Development Program of China 2021ZD0202803National Natural Science Foundation of China 82330116National Natural Science Foundation of China U23A20533
6 · The paper itself

Abstract

Novel object recognition (NOR), referring to the cognitive ability to differentiate familiar/novel objects, is a fundamental cognitive function essential for daily life. However, the mechanisms underlying the encoding of novel preference information remain incompletely understood. Here, we demonstrate that the fibronectin1-expressing subiculum-entorhinal circuits selectively govern NOR retrieval. Subicular pyramidal neurons are able to differentiate between familiar and novel objects, and bidirectionally regulate the retrieval of NOR. At the circuit level, subicular-entorhinal projections, rather than those targeting the anterior nucleus of thalamus, mammillary bodies or retrosplenial cortex, encode novel object preference and regulate NOR retrieval. Importantly, fibronectin1 is identified as a key functional molecular component expressing within this glutamatergic circuit, gates neuronal excitability by regulating the large conductance Ca

Indexed as

Entorhinal CortexFibronectinsHippocampusRecognition, PsychologyAnimalsMaleMicePyramidal CellsFibronectinsentorhinal cortexfibronectin1neural circuit, novel object recognitionsubiculum

Identifiers

PMID41984531
PMCPMC13334995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.